Goserelin to preserve ovarian function in aplastic anemia stem cell transplant patients
Part of Blood & lymphatic clinical trials.
This study tests whether a medication called goserelin (which temporarily 'puts the ovaries to sleep') can help protect ovarian function in women with aplastic anemia who are having a stem cell transplant. The goal is to see if it helps preserve the chance of getting your period back after the transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with severe aplastic anemia (a bone marrow disorder) and are scheduled for a stem cell transplant from a donor.
- You are a female between 14 and 50 years old and have regular menstrual periods before the transplant.
- You (or your legal guardian) agree to join the study and sign a consent form.
- Your doctors expect you to live for more than one year, so there is enough time to see if your periods return.
- You do not have severe heart, liver, or kidney problems, and you are not allergic to goserelin or similar drugs.
- You have not already gone through menopause, and you do not have significant gynecological conditions like PCOS or endometriosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called goserelin can help protect your ovaries and keep your menstrual cycle regular during a stem cell transplant. If you are a woman planning this transplant, it may help preserve your fertility and hormone health.
This study tests whether a medicine called goserelin (Zoladex) can help protect your ovaries during a stem cell transplant, so your periods may come back after treatment. If you qualify, you would receive this medicine as part of your transplant care.
This trial transplants ovarian tissue from a healthy sister to a woman with early menopause, so she might be able to get pregnant. The study will see if this approach is safe and effective in restoring fertility.
This trial is testing whether giving the drug goserelin in a different spot on the body works just as well for suppressing ovarian function in premenopausal women with hormone receptor positive breast cancer. You may be a fit if you've already been on goserelin shots in your abdomen for at least 6 months.
This trial tests two hormone-blocking injections (leuprolide and goserelin) to suppress ovarian function in premenopausal women with breast cancer. It aims to see how well these drugs work when taken with standard hormone pills.
This trial studies whether an injection of your own PRP (platelet-rich plasma) can improve how your ovaries work in people with early ovarian failure. If it helps, it may lead to better hormone balance and return of more regular ovulation and periods.
Hear when a new Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.